PAVmed

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PAVmed and other ETFs, options, and stocks.

About PAVM

PAVmed, Inc. is a multi-product life sciences company, which engages in the innovation, development, acquisition, and commercialization of products that target unmet medical needs with large addressable market opportunities. Its products include Lucid Diagnostics and Veris Health. 

CEO
Lishan Aklog
CEOLishan Aklog
Employees
41
Employees41
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2014
Founded2014
Employees
41
Employees41

PAVM Key Statistics

Market cap
13.59M
Market cap13.59M
Price-Earnings ratio
-0.19
Price-Earnings ratio-0.19
Dividend yield
—
Dividend yield—
Average volume
38.05K
Average volume38.05K
High today
$1.75
High today$1.75
Low today
$1.59
Low today$1.59
Open price
$1.69
Open price$1.69
Volume
11.04K
Volume11.04K
52 Week high
$28.44
52 Week high$28.44
52 Week low
$1.17
52 Week low$1.17

Stock Snapshot

The current PAVmed(PAVM) stock price is $1.70, with a market capitalization of 13.59M. The stock trades at a price-to-earnings (P/E) ratio of -0.19.

During the trading session on 2026-11-17, PAVmed(PAVM) shares reached a daily high of $1.75 and a low of $1.59. At a current price of $1.70, the stock is +6.9% higher than the low and still -2.6% under the high.

Trading activity shows a volume of 11.04K, compared to an average daily volume of 38.05K.

The stock's 52-week range extends from a low of $1.17 to a high of $28.44.

The stock's 52-week range extends from a low of $1.17 to a high of $28.44.

PAVM News

TipRanks 3d
PAVmed Earnings Call Highlights Lucid and Device Progress

Pavmed ((PAVM)) has held its Q3 earnings call. Read on for the main highlights of the call. PAVmed’s earnings call carried a predominantly positive tone as Luc...

Seeking Alpha 4d
PAVmed to post Q3 non-GAAP adjusted net loss of $1.2M

PAVmed to post Q3 non-GAAP adjusted net loss of $1.2M Nov 13, 2026, 9:24 AM ET PAVmed Inc. (PAVM) Stock By : Ananya Roy, SA News Editor PAVmed ( PAVM) said on F...

PAVmed to post Q3  non-GAAP adjusted net loss of  $1.2M
TipRanks 4d
PAVmed Reports Medicare Reimbursement for Lucid EsoGuard Tests

PAVmed ( (PAVM) ) has issued an announcement. On November 13, 2026, PAVmed reported that Lucid Diagnostics had begun receiving Medicare payments in October for...

More PAVM News

TipRanks 4d
PAVmed reports preliminary Q3 adjusted EPS (19c) vs. (62c) last year

Reports preliminary Q3 revenue $41,000 vs. $5,000 last year. PAVmed (PAVM) had cash and cash equivalents of $8.9M, including restricted cash of $5.3M, as of Sep...

TipRanks 5d
Lucid Diagnostics Reports Third-Quarter Results and Medicare Progress

Lucid Diagnostics ( (LUCD) ) has shared an update. Lucid Diagnostics, a commercial-stage cancer prevention medical diagnostics company and PAVmed subsidiary, r...

People also own

Based on the portfolios of people who own PAVM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.